CAPA Blog

FDA Targets Opioid Drug Abuse With Guidelines Aimed At Manufacturers

The Food and Drug Administration (FDA) announced Wednesday it’ll help manufacturers develop abuse-deterrent opioid drugs. “The science of abuse-deterrent medication is rapidly evolving, and the FDA is eager to engage with manufacturers to help make these medications available to patients who need them,” Dr. Margaret A. Hamburg, the FDA’s commissioner, said in a press release. “We feel this is a key part of combating opioid abuse. We have to work hard with industry to support the development of new formulations that are difficult to abuse but are effective and available when needed.” Read more

Leave a Reply

Your email address will not be published. Required fields are marked *